Korean J Hematol.  2009 Jun;44(2):74-81. 10.5045/kjh.2009.44.2.74.

Prognostic Significance of FLT3 Internal Tandem Duplication in Acute Myeloid Leukemia with Normal Karyotype

Affiliations
  • 1Department of Laboratory Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea. jeong418@medimail.co.kr
  • 2Department of Internal Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.
  • 3Paik Institute for Clinical Research, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.

Abstract

BACKGROUND: Activating mutations of the fms-like tyrosine kinase 3 gene (FLT3) by internal tandem duplication (ITD) in the juxtamembrane region are found in 20~30% of the adults with acute myeloid leukemia (AML). The allelic ratio of FLT3/ITD (ITD-AR), as assessed by Genescan analysis, has been reported to carry prognostic significance in AML patients who have normal karyotype.
METHODS
FLT3/ITD was studied by PCR in 113 adults with AML including 55 patients with normal karyotype. Genescan analysis was performed for the PCR products to determine the allelic distribution. The results were correlated with the prognostic factors.
RESULTS
FLT3/ITD was found in 23% of the total AML patients and in 32.7% of those patients with normal karyotype. The mutation was related to a high WBC count, a high serum LD level and a low percentage of CD34 positive cells. The ITD-AR ranged from 0.05 to 8.27 (median, 0.61). The patients with a high ITD-AR (> or =0.7) had significantly higher WBC count and LD level than those without FLT3/ITD. On multivariate analysis, a high ITD-AR as well as FLT3/ITD were confirmed to be independent adverse prognostic factors for AML patients with normal karyotype.
CONCLUSION
This study demonstrated that a high ITD-AR and FLT3/ITD had major adverse impacts on the prognostic relevance for AML patients with normal karyotype.

Keyword

Acute myeloid leukemia; Normal karyotype; FLT3 internal tandem duplication
Full Text Links
  • KJH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr